A Dose Finding Study of ZW49 in Patients With HER2-Positive Cancers

A Dose Finding Study of ZW49 in Patients With HER2-Positive Cancers
Conditions: HER2-expressing Cancers

Interventions: Drug: ZW49

Sponsors: Zymeworks Inc.

Active, not **RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

December 12, 2023Comments OffClinicalTrials.gov | Gastroenterology Clinical Trials | Gastroenterology Studies | US National Library of Medicine
Comments